A new customer of mine is working on mrna cancer treatments. From reading up on it and discussing it with them, it seems like you need to adapt this for every patient. How does that fall in line with currently testing requirements for new medication?
We could hardly have big multi year trials for every patient, right?
theedopes3 karma
Asking here, since it's topical:
A new customer of mine is working on mrna cancer treatments. From reading up on it and discussing it with them, it seems like you need to adapt this for every patient. How does that fall in line with currently testing requirements for new medication? We could hardly have big multi year trials for every patient, right?
View HistoryShare Link